With the population over 65 expected to grow at twice the rate of the Australian population, likely winners include healthcare companies and financial services.
Integral Diagnostics (OTCMKTS:ITGDF – Get Rating) was downgraded by equities research analysts at Royal Bank of Canada to a “sector perform” rating in a research note issued to investors on Monday, The Fly reports. Integral Diagnostics Stock Performance OTCMKTS ITGDF opened at $2.00 on Monday. Integral Diagnostics has a 1 year low of $2.00 and […]
Weekly Broker Wrap: Jarden's preferred exposures to online retail, online penetration trends & the improving outlook for diagnostic imaging in Australia
Cincinnati, OH (PRWEB) January 12, 2023 Today, Integral Diagnostics (IDX), a leading provider of medical imaging services across Australia and New Zealand,
Welcome to the December 2022 Investment Update for the Switzer Dividend Growth Fund . Click here to download the report. Performance Summary . | January 9, 2023